- Home
- TVTX vs CGAU Comparison
TVTX vs CGAU Comparison
Compare TVTX & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- CGAU
- Stock Information
- Founded
- TVTX 2008
- CGAU 2002
- Country
- TVTX United States
- CGAU Canada
- Employees
- TVTX N/A
- CGAU N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- CGAU Precious Metals
- Sector
- TVTX Health Care
- CGAU Basic Materials
- Exchange
- TVTX Nasdaq
- CGAU Nasdaq
- Market Cap
- TVTX 1.5B
- CGAU 1.2B
- IPO Year
- TVTX N/A
- CGAU N/A
- Fundamental
- Price
- TVTX $18.37
- CGAU $5.83
- Analyst Decision
- TVTX Buy
- CGAU Buy
- Analyst Count
- TVTX 12
- CGAU 2
- Target Price
- TVTX $24.58
- CGAU $11.00
- AVG Volume (30 Days)
- TVTX 1.2M
- CGAU 955.8K
- Earning Date
- TVTX 02-13-2025
- CGAU 02-20-2025
- Dividend Yield
- TVTX N/A
- CGAU 3.44%
- EPS Growth
- TVTX N/A
- CGAU N/A
- EPS
- TVTX N/A
- CGAU 0.47
- Revenue
- TVTX $203,447,000.00
- CGAU $1,252,073,000.00
- Revenue This Year
- TVTX $62.38
- CGAU $16.08
- Revenue Next Year
- TVTX $57.65
- CGAU N/A
- P/E Ratio
- TVTX N/A
- CGAU $11.88
- Revenue Growth
- TVTX 57.08
- CGAU 29.99
- 52 Week Low
- TVTX $5.12
- CGAU $4.47
- 52 Week High
- TVTX $20.33
- CGAU $7.82
- Technical
- Relative Strength Index (RSI)
- TVTX 52.05
- CGAU 48.88
- Support Level
- TVTX $16.80
- CGAU $5.67
- Resistance Level
- TVTX $18.76
- CGAU $6.11
- Average True Range (ATR)
- TVTX 0.90
- CGAU 0.18
- MACD
- TVTX 0.02
- CGAU 0.03
- Stochastic Oscillator
- TVTX 61.57
- CGAU 53.33
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
About CGAU Centerra Gold Inc.
Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets worldwide. The company manages its reportable operating segments by a combination of geographic location and products. The Kyrgyz Republic segment includes the operations of the Kumtor Gold Project. The Turkish segment represents the development of the OksUt Project. The North America Gold- Copper segment represents the operations of the Mount Milligan Mine. The North America Molybdenum segment includes the operations of the Langeloth processing facility and the care and maintenance activities of the Endako and Thompson Creek Mines.